[go: up one dir, main page]

WO2025207088A1 - Système automatisé fermé et procédé de traitement de cellules multiplex - Google Patents

Système automatisé fermé et procédé de traitement de cellules multiplex

Info

Publication number
WO2025207088A1
WO2025207088A1 PCT/US2024/021769 US2024021769W WO2025207088A1 WO 2025207088 A1 WO2025207088 A1 WO 2025207088A1 US 2024021769 W US2024021769 W US 2024021769W WO 2025207088 A1 WO2025207088 A1 WO 2025207088A1
Authority
WO
WIPO (PCT)
Prior art keywords
processing chamber
cassette
piston
swinging bucket
rotor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/US2024/021769
Other languages
English (en)
Inventor
Miguel Angel LOPEZ RAMIREZ
Shengdong LIU
Yu-Tsueng Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diagnologix LLC
Original Assignee
Diagnologix LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnologix LLC filed Critical Diagnologix LLC
Priority to PCT/US2024/021769 priority Critical patent/WO2025207088A1/fr
Publication of WO2025207088A1 publication Critical patent/WO2025207088A1/fr
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3693—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
    • A61M1/3696—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging with means for adding or withdrawing liquid substances during the centrifugation, e.g. continuous centrifugation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers

Definitions

  • PLAX parallel automated closed system
  • One aspect of PLAX involves controlling a piston inside a syringe-processing chamber using an external hydraulic pump
  • the present disclosure enables conventional laboratory methods to be intuitively and seamlessly executed as closed automated processes.
  • the system may be configured to perform a variety of current laboratory routines as a closed automated process, including processes such as swinging bucket centrifugation, fixed angle centrifugation and multi-well plate centrifugation.
  • a closed system for blood sample processing to separate biological components may include: a centrifuge having a rotor, said centrifuge being configured to centrifugate a blood sample; a processing chamber attached to the rotor, said processing chamber having a first end and a second end, and is configured to contain at least one blood sample; a piston housed in the processing chamber, said piston configured to move between the first position closer to a first end of the processing chamber and second position closer to a second end of the processing chamber, the second end being located opposite of the first end; and a plurality of tubes connecting the processing chamber to the at least one blood sample; wherein actuation of the piston making the piston move dispels fractions of the blood sample during centrifugation or at rest to at least one fraction bag.
  • a method of cell selection from a blood sample may include: a) priming the system by removing air from processing chamber through actuation of piston in a first direction via a hydraulic pump; b) pumping blood into the processing chamber, wherein said processing chamber is housed in a swinging bucket cassette; c) pumping density gradient separation media into the processing chamber; d) actuating centrifugal rotation of rotor to which the swinging bucket cassette is attached; and while performing centrifugation, moving a piston within the processing chamber, performing in sequence the following steps: e) extracting erythrocytes from the processing chamber; f) extracting density gradient separation media from the processing chamber; g) extracting mononuclear cells from the processing chamber; h) extracting plasma from the processing chamber; i) ceasing centrifugation, closing valves, and stabilizing pressure.
  • the system may be structured to allow fluids to flow in and out of a processing chamber either when the system is stationary or under centrifugation, thereby allowing fractions of different densities to be extracted or separated.
  • the bundle of tubing lines that route into each of the separated bag fractions is possible due to the integration of either individual or multi-channel pinch valves.
  • sterility of operating cells and reagents is maintained through a functionally closed system employing components that do not have any direct contact with the fluids being processed
  • all fluid/sample processing is strictly conducted within the confines of medical grade tubing, and its manipulation is performed using noninvasive peristaltic pumps and pinch valves.
  • the system arrangement and architecture allow each process to use disposable tubing kits that run through retaining channels within each pinch valve, providing a tight grip for routing fluid, and eliminating any cross contamination between adjacent lines.
  • the procedure of moving fluid in and out of the processing chamber during centrifugation or stationary is made possible due to the integration of a hydraulic pump.
  • the hydraulic system is a plunger control subsystem comprising weight cells, stepper motors, and a processing buffer syringe, along with solenoid pinch valve plates/holders with retaining channels to route the fluid flow from a premixing subsystem, or reagent bags (blood, density gradient media) through a bundle of tubes within the system to the desired container or processing chamber.
  • reagent bags blood, density gradient media
  • This system like an apheresis machine, can be categorized in three subsystems or modules that are required for cell isolation: the sorting module (Ms), control module (Me) and electronics module (Me).
  • the system is tailored for fully automation through the incorporation of standard and unique components for microbubble-based technologies, as described in U.S. Patent Publication No. U.S. 10,479,976 B2, and for cell processing.
  • Components include a centrifuge, peristaltic pumps, pinch valves, actuators, and diverse sensors such as: ultrasonic range finders, optical sensors, imbalance sensors, weight cells, pressure sensors, and stepper motors.
  • the control module (Me) comprises all necessary components for fluid management, logic, and operator interfacing.
  • the sorting module includes the primary processing chamber for the isolation process.
  • a primary function of the sorting module is to provide mixing of input reagents (targeted microbubbles, blood, cells, or density gradient media), and accurate control of the volume for each step of the isolation process.
  • the electronics module (Me) contains all the physical components of the system, which are controlled with microcontrollers and chips, ensuring all the hardware components operate within their specified voltage and clock rate. The control system helps with data transmission, parallel processing, and handling interruptions. Users can operate the system via a graphical user interface (GUI) that is displayed on a built-in screen.
  • GUI graphical user interface
  • Processing target cells bound by microbubbles involves floating them to the liquid surface, thereby separating them from the remaining cells that sink.
  • a centrifugation system may be used to expedite the process, especially for pelleting unbound cells whose densities are close to that of the buffer solution.
  • the centrifugation system employs a seal-less anti-twisting centrifuge process that allows the system to spin the rotor base, while continuously flowing reagents in and out of a main processing chamber.
  • a swinging bucket cassette holds a syringe-like isolated container, namely a processing chamber, that is detachable and openable for easy installation and connection of the single-use tubing set kit.
  • the swinging cassette can be vertically rotated to facilitate mixing samples (e.g., microbubbles and target cells) via the use of a mixing device.
  • the PLAX system integrates sensors to situate the centrifuge rotor to a fixed position so that the cassette and the mixing device can be correctly aligned. Additionally, the system may integrate built-in triple axis accelerometers, allowing the monitoring of the stability and imbalance of the process when subjected to any abrupt, sudden, or unexpected external factor.
  • a further aspect and application of this disclosure is the streamlined production of multiple CAR-T cells in parallel, manufactured by microbubble-based technologies in a complete closed environment, thereby overcoming the recurrent cross contamination issues common in open systems.
  • This separation system and method can increase sample processing throughput, while also lowering the manufacturing labors and costs.
  • the dimensions and housing space do not change significantly for a multiplex machine.
  • the simple and streamlined processing system of microbubble-based technologies further reduces the cost and boosts cell product quality.
  • FIG. 1 A shows a side view of a PLAX system for parallel multi-sample centrifugation using a swinging bucket mechanism.
  • FIG. IB shows a top view of the rotor/cassette subsystem of a PLAX system for parallel multisample centrifugation using a swinging bucket mechanism.
  • FIG. 3A shows a top view of an empty foldable swinging bucket cassette in an open configuration.
  • FIG. 3B shows a side perspective view of the foldable swinging bucket cassette in a closed configuration
  • FIG. 4B shows exemplary centrifugation in two different directions with respective processing chamber configurations shown in Figure 4A.
  • FIG. 5 shows an application of the PLAX system wherein microbubbles are used for cell isolation by processing microbubble bound cells.
  • FIG. 7B shows a top perspective view of the rotor/cassette subsystem including two cassettes.
  • FIG. 10 shows a schematic of a PLAX cabinet and systematization containing instrumentation and devices for controlling processing.
  • FIG. 11A shows a schematic of a PLAX in-line monitoring subsystem.
  • FIG. 11B shows a close-up view of connectors of the PLAX in-line monitoring subsystem.
  • FIG. 12 is a schematic of a PLAX system according to an embodiment of the present disclosure.
  • FIG. 13A shows the priming process step of the embodiment shown in Figure 12.
  • FIG. 13C shows the density media-in process step of the embodiment shown in Figure 12.
  • FIG. 13D shows the centrifugation process step of the embodiment shown in Figure 12.
  • FIG. 13E shows the erythrocyte collection process step of the embodiment shown in Figure 12.
  • FIG. 13F shows the density gradient media extraction process step of the embodiment shown in Figure 12.
  • FIG. 131 shows the mononuclear cell extraction process step of the embodiment shown in Figure 12.
  • FIG. 13J shows the plasma extraction process step of the embodiment shown in Figure 12.
  • FIG. 14A shows a bar plot graphing accuracy over pumping steps for reagents in for a hydraulic pump.
  • FIG. 14B shows a bar plot graphing accuracy over pumping steps for reagents out for a hydraulic pump.
  • FIG. 14C shows a bar plot graphing accuracy over pumping steps for reagents towards cassette for a peristaltic pump
  • FIG. 14D shows a bar plot graphing accuracy over pumping steps for flush PBS/washing for a peristaltic pump.
  • FIG. 14E shows a comparison of the accuracy of the respective plots in Figures 14A-14D
  • FIG. 15 shows a plurality of plots for hyperbolic, linear, and stepwise pressurization and depressurization.
  • FIG. 1A shows a side view of the PLAX system that can perform parallel multi-sample centrifugation in fashion familiar to biomedical researchers and staff.
  • Figure 1A specifically focuses on a swinging bucket mechanism.
  • a bundle of flexible medical grade tubes 1 is located at the upper extremity of the PLAX system.
  • the bundle of tubes 1 interface with a spring adapter 2, which is attached to a tube locking input 3 that ensures that the tubing 1 remains stationary and tight during the entire separation process.
  • the central tubing 1, which may be made of biocompatible materials, is curvedly routed through an arm housing 4, secured via a ring enclosed structure input 5 and ring enclosed structure output 6 having stoppers 7 to prevent the tubing 1 from interfering with the centrifugation/separation process.
  • the curved arm housing 4 is counterweighted with a counterweight structure 9 with similar weight in the opposite direction of the system to promote smooth operation and balance under centrifugation.
  • an additional arm 15 may be provided as a counterweight.
  • Arm housing 4 and counterweight 9 are mechanically fixed to a seal-less anti-twisting centrifuge 10, therefore rotating during centrifugation.
  • the core and gear of the centrifuge 10 include a central centrifuge housing 11 formed of material that allows its secure operation and isolation from the rest of the system.
  • a rotational element 12 is mounted on a mechanical fixing, namely a central bush, fitted in the upper extremity of the centrifuge 10, while the rotor 13 is attached to the central bush ensuring proper alignment when inserted/positioned into the centrifuge rotor 13.
  • a gear set configured as outlined in one ofU.S. Patent Publication Nos. US 3586413 A, US 4425112 A, and US 4900298 A
  • the rotational speed ratio between rotor 13 and centrifuge 10 is precisely 2:1 upon activation of motor 14.
  • Arms 15 are placed onto the rotor 13 to allow for the positioning of a swinging bucket cassette 16 that includes a locking mechanism 17.
  • the swinging bucket cassette 16 houses a processing chamber 26.
  • the bundle of tubes 1 is routed towards the inside of the central centrifuge housing 11 in a loop-like fashion, and is further attached to a tube locking output 19. Maintaining the bundle of flexible tubes 1 secured and fixed in both the upper and lower extremities of the centrifuge 10 via a respective tube locking input 3 and tube locking output 19, prevents twisting of the tubes 1 under centrifugation by routing the tubes 1 in a “U” shape.
  • a tube diverter 18 allows the re-routing of each of these tubing lines through the cassette 16 and towards the corresponding inlets and outlets of the processing chamber 26, via retaining channels 20 on the arms 15 and rotor 13.
  • a frame 21 may be located in the periphery of the centrifuge 10 to allow for the placement of distinct sensors and devices in order to ensure a smooth processing operation and system performance.
  • the PLAX frame 21 may be equipped with ultrasonic sensors 22 that allow the centrifuge rotor 13 to be situated in a fixed position and to align the swinging bucket cassette 16 with the mixing device 24.
  • a built-in triple axis accelerometer 23 may be integrated within the PLAX system as a safety feature, allowing the monitoring and stabilization of the system for imbalances due to any abrupt, sudden, or unexpected external factor.
  • FIG. IB shows a top view of the described PLAX system, specifically the rotor/cassette subsystem.
  • the swinging bucket cassettes 16 may be inserted/placed in the central centrifuge rotor 13 via incorporated rotor bucket supports 25, allowing the swinging bucket cassettes 16 to remain seated at a resting vertical position.
  • rotor 13 may be engaged and driven via a single motor 14.
  • Arms 15 are placed onto the rotor 13 to allow for the positioning of a swinging bucket cassette 16 and engagement via locking mechanism 17.
  • a tube diverter 18 may be placed proximate to the central axis of rotor 13 to facilitate the re-routing of respective tubing lines through the cassette 16.
  • FIG. 2A shows an inside view of a PLAX swinging bucket cassette 16, which holds a processing chamber 26.
  • the processing chamber 26 may be characterized as a syringe-like isolated container comprising an upper body 27 and a lower body 28.
  • a piston 29 is disposed between the upper body 27 and lower body 28.
  • the processing chamber 26 is sealed with a cap 30 and equipped with an O-ring 31 in the upper body 27 of the processing chamber 26, thus ensuring airtightness between the upper section of the processing chamber 26 and the piston 29.
  • the processing chamber 26 is made of a medical grade transparent material such as polycarbonate.
  • the PLAX system uses the piston 29 to maintain a closed continuous system. Therefore, samples within the medical grade syringe barrel processing chamber 26 can be moved in or out anytime, even during centrifugation, due to the incorporation of a plurality of inlet cavities 34 and outlet cavities 35 within the swinging bucket cassette 16.
  • Input tubing 38 (comprising part of bundle of tubes 1) is connected to the pre-mixing subsystem 124 and buffer bag 113, thus routed via incorporated input retaining channels 39 within the cassette 16, where the input retaining channels 39 are configured to allow for tubing placement and positioning. Similarly, the resultant diverse factions outputted from the centrifugation process are redirected towards their corresponding waste bag 95 or fraction collection container 96, 97, 98 via output tubing 40. Outlet tubing 40 is routed similarly via its analogous output retaining channels 41.
  • FIG. 2B shows a view of the processing chamber 26 and related tubing connections independent of the housing. Additionally, in the embodiment shown in Figure 2B, the processing chamber 26 is oriented in a second configuration, such that the lower body 28 of the processing chamber 26 may be proximate to the hinge 42. As is apparent, the swinging bucket cassette 16 may be configured to house the processing chamber 26 and associated tubing and connections regardless of whether the processing chamber 26 is arranged in the first or second orientation.
  • FIG. 3A shows the folding housing in an open configuration without the processing chamber 26 inserted into it.
  • the inside of the cassette 16 features input retaining channels 39 and output retaining channels 41 to accommodate tubing, a channel for a hydraulic pump 123, as well as a pocket 46 for housing the processing chamber 26.
  • the cassette 16 may include a hinge mechanism 42 to facilitate easy foldability, allowing it to get into close contact with its reciprocal cassette 45.
  • the swinging bucket cassette 16 is detachable and openable for easy installation and connection between the processing chamber 26 and the single use set/bundle of tubes 1.
  • the cassette 16 may be designed with a pocket 46, specifically tailored to fit the processing chamber 26 in two orientations depending on user processing preferences.
  • FIG. 3B shows the outside of the housing when the foldable cassette 16 is in a closed configuration.
  • both symmetrical or non- symmetrical shaped parts of the swinging bucket cassette 16 form a specific pattern 43 that mirrors its cassette counterpart pattern 49, therefore allowing the respective sides of the cassette 16 to remain fixed and closed with a cassette locker 17 prior processing or centrifugation.
  • cassette locker 17 has a lock and release latch mechanism 50 that grants ease of use by enabling effortless opening and closing.
  • cassette locker 17 facilitates the formation of a physical support 48 for rotation and mixing purposes by the mixing device 24 (shown in Figure 6) forming a bushing 47, when getting placed in the central rotor 13 of the PLAX system, and when a given sample is under an incubation or washing protocol.
  • FIG. 4, 5, and 13 show diagrams applications of the present disclosure for novel microbubblebased cell separation, activation, expansion, and transduction (Patent US10479976B2, US20220154150A1) and convenient integration into other cell processing workflows, such as density based gradient separation (DGBS), to accomplish automation without human intervention.
  • DGBS density based gradient separation
  • FIG. 4A shows two different embodiments of the contents of processing chambers 26 configured to be positioned on the rotor 13 in opposite directions.
  • the processing chamber 26 includes an upper body 27 and the lower body 28 having a tapered end.
  • the piston 29 is arranged proximate to the end of the upper body 27.
  • the piston 29 is urged towards the lower body 28.
  • Erythrocytes 51 are provided closest to the piston 29, followed by a density separation medium 52, mononuclear cells 53, and plasma 54 proximate to the lower body 28.
  • the piston 29 is also arranged proximate to the end of the upper body 27, and the piston 29 similarly is urged towards the lower body 28.
  • plasma 54 is provided closest to the piston 29, followed by mononuclear cells 53, a density separation medium 52, and erythrocytes 51 proximate to the lower body 28.
  • FIG. 4B shows exemplary centrifugation in two different directions with the respective processing chamber 26 content configurations shown in Figure 4A, which may be switched alternatively, as enabled by the design of the swinging bucket cassette 16.
  • Rotor 13 is arranged in an upright configuration, and rotates about an axis.
  • One or more rotor bucket supports 25 are provided on the rotor 13 to allow for attachment of the swinging bucket cassettes 16. Swinging bucket cassettes 16 can get inserted/placed in the central centrifuge rotor 13 due to the incorporation of rotor bucket supports 25, thus allowing it to remain seated, at a resting vertical position.
  • erythrocytes 51 and the density separation medium 52 can be removed, while maintaining mononuclear cells 53 and plasma 54 within the processing chamber 26.
  • mononuclear cells 53 can be retained and washed in the processing chamber 26, while first extracting the plasma 54. Therefore, the washed mononuclear cells 53 can be used for subsequent procedures, such as targeted microbubble-based cell isolation 56, T cell activation, transduction, and short-term cell culture, without needing to leave the processing chamber 26.
  • FIG. 5 shows an application of PLAX system wherein microbubbles 55 are used for cell isolation by processing microbubble bound cells. This allows for specific and relatively easy separation from the rest of non-targeted cells 145, as the bound cells get separated and the others tend to sink, even without centrifugation.
  • the piston 29 contained within the processing chamber 26 can move from the upper body 27 to the lower body 28 of the processing chamber 26. This is enabled by its tubing 36 in connection with a hydraulic pump 123. As the hydraulic pump 123 moves liquid out through the hydraulic tubing 36, the piston 29 within the processing chamber 26 moves down moving liquid out of the processing chamber 26, and vice versa.
  • the PLAX system is subject to a priming process from the hydraulic tubing 36 to the degassing chamber 118, followed by the transfer of blood from the mixing system 124, or blood bag 141 into the processing chamber 26.
  • the blood may contain erythrocytes 51, mononuclear cells 53, and plasma 54.
  • microbubbles 55 are introduced into the processing chamber 26, and the swinging bucket cassette 16 is mixed by the mixing device 24 for a pre-set period of time in accordance with a given protocol.
  • bound cells e g., microbubbles 55 attached to targeted cells 146
  • the rest of non-targeted cells 145 are extracted from the processing chamber 26.
  • the lipid shelled microbubbles 55 can undergo dissolution in 1-2 days spontaneously, or immediately by increasing ambient pressure as described in U.S. Patent US 10,479,976 B2 and U.S. Patent Application Publication US 2022/0154150. This is a very useful property for streamlining the cell processing workflow and easing engineering complexity for automation.
  • Microbubbles 55 bound to target cells 146 can be quickly disrupted by increasing ambient pressure to about 2 atm by moving the piston 29 with the hydraulic pump 123 and increasing the internal pressure within the processing chamber 26. A greater or lesser ambient pressure may be set depending on the concentration. Increasing the internal pressure for microbubble 55 disruption may be achieved not only by moving the piston 29 downwards, but also with the use of an air compressor connected to the upper body 27 or lower body 28 of the processing chamber 26, or with the use of hydrostatic pressure.
  • FIG. 6 shows the PLAX cassette/chamber subsystem mixing mechanism.
  • the mixing mechanism includes the mixing device 24 disposed near the base of the structure.
  • a moving/extending/reaching structure 57 extends upwards from the base, and may be adjusted in translational motion to move the swinging bucket cassette 16 disposed at the distal end of the moving/extending/reaching structure 57.
  • the moving/extending/reaching structure 57 may connect to the cassette bottom 58 of the swinging bucket cassette 16.
  • the moving/extending/reaching structure 57 can for instance include a telescoping arm mechanism.
  • mixing device 24 may continue to facilitate mixing of the samples (e.g., microbubbles 55 and target cells 146) by moving the cassette bottom 58.
  • the mixing device 24 may comprise any combination of linear actuators, pneumatic systems, motors, and robotic arms.
  • the point of contact may be physical, magnetic, a lever, etc.
  • FIGs. 7A-7D show various views of the rotor/cassette subsystem.
  • the figures demonstrate the range of motion of the swinging bucket cassette 16, and its relationship with the rotor 13, rotational element 12, and associated tube channels. While two cassettes 16 are depicted in these figures, additional cassettes 16 can be symmetrically installed.
  • FIG. 7A shows an exploded perspective view of the rotor/cassette subsystem that includes the rotor 13 and swinging bucket cassette 16.
  • the assembly includes rotor 13 disposed atop a rotational elementl2 to ensure proper alignment when positioned on centrifuge 10.
  • Arms 15 extend outwards from the rotor 13, and include intermediate space to permit the cassette 16 to be rotatably attached between respective arms 15.
  • the cassette 16 may be secured by a cassette locker 17 having a physical support 48 and a lock and release latch mechanism 50 that enables effortless opening and closing.
  • tubing and related elements for routing the tubing through the central axis of rotor 13.
  • a tube diverter 18 re-routes each of these tubing lines 1 towards the cassettes 16 through retaining channels 20 included in the arms 15, with attachment to tube locking output 19.
  • bushing 47 may be included at the connection points between arms 15 and cassette 16 to reduce friction.
  • FIG. 7C and FIG. 7D show side views of the assembly, wherein the cassettes 16 are oriented vertically and horizontally, respectively.
  • cassettes 16 Upon the positioning of cassettes 16, they are closed, secured, and locked by the attachment of the cassette lockers 17.
  • the cassettes 16 When in a resting position, the cassettes 16 are positioned in a vertical orientation aligned parallel to the centrifuge 10 gears and centrifuge housing 11 (seen in Figure 1 A), as is typical for a swinging bucket centrifuge system.
  • the swinging bucket cassettes 16 transition from the vertical resting position shown in Figure 7C to a horizontal positioning shown in Figure 7D, being dragged by the outward g-force exerted by the speed of rotation. While rotating in the horizontal orientation during centrifugation, particle separation results.
  • FIGs. 8A and 8B respectively show a front view and a top perspective view of a PLAX hydraulic pump subsystem comprising the hydraulic pump 123 that controls positioning and fluidics for piston 29.
  • the hydraulic pump 123 is a plunger control subsystem that employs a stepper motor 63 coupled to a leadscrew 61 via a shaft coupling connector 62 to drive a plunger-flange 70 of a processing buffer container 73 (e.g., medical syringe barrel) Hydraulic tubing 36 may extend outwards from the bottom of processing buffer container 73.
  • Sensors such as weight cells 68 may be integrated into the subsystem to allow for feedback control and accurate volume transfer during piston 29 translation within the processing chamber 26.
  • the hydraulic pump 123 subsystem comprises a movable pressurization platform 59 that moves along the length of the leadscrew 61 via a leadscrew translation adaptor 77 (e.g., leadscrew nut).
  • the movable pressurization platform 59 includes corresponding sensor cavity-coupling integrations 67 to which weight cells 68 may attach.
  • a syringe attachment 69 may be disposed between weight cells 68 and flange 70 on the movable pressurization platform 59.
  • Linear rail shaft optical axis rod 60 and multiple rotational elements 66, 76 may be provided to facilitate translation of the dynamic pressurization platform 59.
  • Driving the flange 70 with proper stability may be achieved by providing any combination of a top support structure 64, a bottom support structure 65, and a stepper motor support structure 75.
  • the stepper motor support structure 75 may be arranged proximate to the stepper motor 63.
  • the top support structure 64 may be included at the top of the hydraulic pump 123, and the bottom support structure 65 may be included proximate to the shaft coupling connector 62.
  • a holder 71 may secure the hydraulic processing buffer container 73 through the barrel flange 72 within the PLAX hydraulic pump subsystem.
  • the hydraulic pump 123 and one peristaltic pump 108 may be installed in the system to move fluid in and out of the syringe-like processing chamber 26.
  • the hydraulic pump 123 system enables accurate fluid volume control, from either a stationary container (e.g., blood sample, washing buffer) or from a pre-mixing subsystem 124, towards feeding sample and reagents, to a rotating processing chamber 26 and extracting fractions into stationary containers 96, 97 and 98.
  • the use of peristaltic pump 108 may additionally be employed to completely transition cell fractions towards stationary containers 96, 97 and 98 and waste to waste bag 95.
  • a sterile flexible cover/enclosure may be applied to the upper part of the hydraulic pump syringe 73 comprising plunger 74, barrel flange 72, and plunger flange 70, to shield contaminants from the environment, as described in U.S. Patent Publication US 4,713,060 A.
  • FIG. 9 shows a schematic of a PLAX pre-mixing subsystem 124. All reagents (e g., microbubbles 55, target cells 146, density gradient media 52 or blood) that are required to be incorporated within the processing chamber 26 prior to processing are held in a pre-mixing subsystem 124 and connected via a medical grade input tubing 38.
  • the PLAX pre-mixing subsystem 124 comprises a stepper motor 90 within a housing 91, coupled to a rod mixer 81 via a coupling connector/adapter 89.
  • the rod mixer 81 connects to a support structure 88 at the end opposite of the coupling connector adaptor 89.
  • the support structure 88 includes rotational elements 87 (e.g., ball bearings) that reduce rotational friction and support axial and radial loads.
  • the rod mixer 81 may be configured to hold and secure multiple input reagent containers 83 (e.g., syringes) simultaneously via a clamp mechanism 82 that allows easy placement and removal when required.
  • the input reagent containers 83 are sealed via a sealing cap 84, coupled with a filter 85 (e.g., 0.2pm filter or membrane) and individually connected to the rest of the system via a tubing connector 86.
  • a filter 85 e.g., 0.2pm filter or membrane
  • FIG. 10 shows a schematic of a PLAX cabinet and systematization containing instrumentation and devices for controlling the processing.
  • the cabinet is the hub for the subsystems detailed in FIG. 8 and FIG. 9, namely hydraulic pump 123 subsystem and reagent/input pre-mixing system 124, as well as the holder of medical components and devices necessary for proper fluidic transport within the system.
  • the cabinet contains a washing buffer bag 113 configured to hold a liquid such as phosphate buffered saline, cell culture media, etc.
  • the tubing extends from the washing buffer bag 113 to the input tubing line 38 of cassette 16, with a buffer pinch valve 107 disposed intermediate the washing buffer bag 113 and cassette 16.
  • the washing buffer bag 113 tubing passes by the output tubing of pre-mixing system 124, which may be sealed by valves 104, 105.
  • the bundle of tubes 1 that respectively are routed curvedly through arm housing 4, towards centrifuge 10 and processing chamber 26 may include input tubing 36, 38, and output tubing 37, 40.
  • Sensors 93, 115 provide real-time data, tracking the processed and employed volume across the system from input to output. Fractions of interest can be collected in bags/containers 96, 97, 98 using individual or multichannel external pinch valves 99, 100, 101, respectively. This prevents leakage and contamination in adjacent lines, and prevents interference with the fluid exiting the processing chamber 26 through a pre-collection pinch valve 103. Similarly, reagents such as microbubbles 55 and target cells 53 may move out from the mixing sub-system 124 towards the processing chamber 26 via the medical grade tubing 1 by opening corresponding pinch valves 104, 105, which may individually correlate to an input reagent container 83 (shown in FIG. 9). Alternatively, the tubing may be multichannel.
  • An optical sensor 120 allows for sensing of colors in the medical grade tubing 1, therefore enabling detection of the distinct fractions exiting the processing chamber 26.
  • the optical sensor 120 may be included between the chamber/rotor subsystem and the plurality of containers 95, 96, 97, 98.
  • the cabinet architecture may optionally incorporate retaining channels 110 for the tubing connections, or housing adapters 109, 111, 112 for various system components, such as the peristaltic pump 108, degassing pinch valve 106, and buffer pinch valve 107, respectively. Any remaining air within the tubing-set for priming purposes is routed through a degassing pinch valve 106 towards a degassing chamber 118, which is coupled to a filter 119 (e.g., 0.2pm filter or membrane). Reagents such as microbubbles 55, target cells 53, or density gradient media 52 are incorporated into the processing chamber 26 via input tubing 38 in the lower body 28 portion of the processing chamber 26.
  • a filter 119 e.g., 0.2pm filter or membrane
  • the PLAX system may include a tube welding subsystem 122 for sealing and closing tubing connected to the processing chamber 26 within the swinging bucket cassette 16. While in operation, this device can execute the continuous and accurate movement of liquid in and out of system via the incorporation of an intuitive user interface screen 117, which may optionally have touch responsive capabilities.
  • the fraction of interest may be cultured within the processing chamber 26 for a short-term period, such as a few days, to allow for completion of the streamlined process of cell sorting, activation, and transduction, prior to transferring the engineered cells to a separate culture bag for longer term cell culture. Such culture bags are widely available commercially.
  • Culture media and CO2 gas can be delivered and exchanged by connecting further tubing lines in addition to the ones currently used to transfer materials into the processing chamber 26 via input tubing 38 and out via output tubing 40.
  • a “water jacket” may be used within the cassette 16 for short cell culture. When needed, the water jacket may be connected to an external pump in the PLAX cabinet that circulates water of desired temperature.
  • FIG. 11 A shows a schematic of the PLAX in-line monitoring subsystem.
  • Standard and specific in-line monitoring modules are implemented within the PLAX system, and may optionally be employed within certain processes for gathering live-on-demand accurate and reliable data within the system.
  • Exemplary monitored parameters include cell morphology, temperature, concentration, and size distribution.
  • This inline-monitoring subsystem comprises a free moving dynamic focusing platform 125 configured to autofocus a microfluidic chamber 126.
  • the microfluidic chamber 126 has an inlet 127 and an outlet 128, via a connector 139, 140 respectively, holding the to-be-analyzed fraction or sample of interest within an enclosed channel that allows for precise control of fluid flow and manipulation of e.g., microbubbles 55 or target cells 53 contained within it.
  • the dynamic platform 125 may move up and down freely, as needed, when focusing and moving though a lead screw 131, which provides guidance.
  • a stepper motor 129 connected to a shaft coupling connector 130 may move the microfluidic chamber 126, which may be reinforced with linear motion axis rail 132 and supported by rail clamps 135.
  • the monitoring sub-system may optionally incorporate a top support structure 133, middle support structure 138 (which may include a plurality of holes), and bottom support structure 134, to improve stability
  • the imaging device 137 is attached parallel to the platform 125 a light source 136 (e.g., LED, infrared, fluorescence or coupled with filters) providing appropriate illumination.
  • a light source 136 e.g., LED, infrared, fluorescence or coupled with filters
  • the beam of light from light source 136 crosses the transparent microfluidic chamber 126 and the exposed pixels of the sample allow for high resolution (pm x pixel) imaging of the sample.
  • Data collection by the in-line monitoring sub-system can be processed to analyze the size, concentration, and shape of the samples (e g , microbubbles 55 and target cells 53) in real-time. These data parameters may be complied as a result of accurate microscope control, image capture, image processing/analysis, including image filtering, noise reduction, segmentation, and detection. Through these features, the system reduces the error inherent to manual sampling with traditional microscopes and hemacytometers, therefore ensuring cell viability and integrity prior cell culture. Observing in real-time the physical characteristics of cells, including their shape, size, identification of abnormalities or changes, is particularly useful for early detection/diagnosis of engineered cell products.
  • FIG. 11B shows a close-up view of connectors 139, 140 of the PLAX in-line monitoring subsystem.
  • Connector 139 corresponds to microfluidic chamber input 127
  • connector 140 corresponds to microfluidic chamber output 128.
  • FIG. 12 shows a PLAX system with instrumentation, subsystems, and devices for controlling processing.
  • the rotor/cassette subsystem of the PLAX system includes the rotor 13 with at least one attached processing chamber 26 containing a piston 29.
  • the processing chamber 26 is sealed by a cap 30.
  • two processing chambers 26 are included.
  • a plurality of tubes connects the rotor/cassette subsystem to the other constituent system elements.
  • the rotor/cassette subsystem is connected to hydraulic pump 123 via tubing with an intermediate pinch valve 143. Another line of tubing connects the rotor/cassette subsystem to a degassing chamber 118 with an intermediate degassing pinch valve 106. A bubble air trapping detection and pressure monitoring sensor 121 may be included between the rotor/cassette subsystem and the degassing pinch valve 106. Tubing may connect the rotor/cassette subsystem to a set of parallel control/electronic module 144. For multiplexing processing, additional bundles of tubes can be simultaneously installed alongside the first sets of tubing using multichannel mechanisms, including multiple-channel pinch valves and peristaltic pumps 108.
  • a further line of tubing connects the rotor/cassette subsystem to waste bag 95 and fraction collection containers 96, 97, 98.
  • Each respective fraction collection container 96, 97, 98 includes a corresponding pinch valve 99, 100, 101 that controls the respective channel, while waste bag 95 corresponds to pinch valve 102.
  • a pre-collection peristaltic pump 108 and an optical sensor 120 may be disposed intermediate the rotor/cassette subsystem and fraction collection containers 95, 96, 97, 98.
  • the rotor/cassette subsystem is connected to a plurality of bags, namely buffer bag 113, blood bag 141, and density gradient separation media bag 142 via respective tubing lines.
  • Each bag 113, 141, 142 has an individual tubing line and a respective pinch valve 107, 104, 105.
  • Blood bag 141 contains the blood input, and the tubing line is sterilely connected to the lower body
  • FIG. 13 shows the processes steps of the embodiment shown in Figure 12.
  • Step 2 “Blood in” (FIG 13B): Vertical position of the cassette 16 is employed while loading the blood sample, density gradient separation media 52, microbubbles 55 or any other solution/reagent into the processing chamber 26. Once the piston 29 is at the bottom of the processing chamber 26, pinch valve 104 and pinch valve 143 open to allow the hydraulic pump 123 to actuate the piston 29 to move upwards, thus letting blood flow from blood bag 141 into the chamber 26.
  • An optical sensor 120 and a bubble air trapping detection and pressure monitoring sensor 121 may be used to detect colors and light absorbance to monitor erythrocytes 51 and other cells in the input tubing 38 or output tubing 40. This enables more
  • Step 3 Density media in: After the blood sample is loaded into the processing chamber 26, the density gradient separation media 52 located in density gradient separation media bag 142 is loaded into the chamber 26. At this point, the piston 29 may be disposed at the middle position of the chamber 26, although position may vary based on the selected processing protocol. By activating the hydraulic pump 123 to move the piston 29 upwards, and opening valve 105 and valve 143, the density gradient separation media 52 is carefully layered below the blood.
  • Step 4 Centrifugation starts, and speed is stabilized according to the selected protocol (e.g., 2400 rpm), with all pinch valves, inlets, and outlets closed. A counter pressure may get established through the hydraulic pump 123 to keep piston 29 static within the processing chamber 26.
  • the cassette 16 with the processing chamber 26 can swivel between a vertical position and a horizontal position due to centrifugation forces.
  • Step 5 “Erythrocyte collection” (FIG 13E): After sedimentation time, the centrifuge 10 speed slowly decreases while maintaining the piston 29 at the same position within the processing chamber 26. Once the centrifuge 10 drops to a predefined speed, the piston 29 moves downwards at a pre-set speed (the value of which can be modified through the protocol/program parameters) via the hydraulic pump 123, for erythrocytes 51 collection and extraction, while maintaining valve 99 and valve 143 open, which respectively correspond to fraction collection container 96 and hydraulic pump 123. Erythrocyte 51 collection is optional, and alternatively erythrocytes 51 may be re-routed and extracted towards the waste bag 95.
  • a pre-set speed the value of which can be modified through the protocol/program parameters
  • Step 6 A washing protocol is normally carried out between the different fraction collection steps by using buffer at buffer bag 113 to clean tubing running towards waste bag 95, therefore ensuring the highest purity across all the steps.
  • the washing protocol is performed by actuating the pre-collection pump 108 and opening valves 102, 107 while maintaining the hydraulic pump 123 and pinch valve 143 closed.
  • fraction #2 density gradient media 52
  • Step 7 The speed of centrifugation decreases until reaching a stop, and the orientation of the processing chamber 26 is switched either within the cassette 16, or by flipping the cassette 16 within the rotor 13 either manually or automatedly Centrifugation starts, and speed is stabilized according to the selected protocol. Due to the possibility of centrifugation in two different directions, fraction #4 (plasma 54) can be extracted from the processing chamber 26 under centrifugation, while retaining mononuclear cells 53. Plasma 54 transitions towards fraction bag 98 by moving the piston 29 downwards with the use of the hydraulic pump 123 and opening valve 101 and valve 143. Plasma 54 may be collected, or in the alternative, re-routed towards waste bag 95 and extracted.
  • Step 8 Mononuclear cells 53 retained within the processing chamber 26 may be used for subsequent processing, such as targeted microbubble-based cell isolation 56, T cell activation by APCs, transduction, and short-term cell culture, without leaving the processing chamber 26.
  • targeted microbubble-based cell isolation 56 T cell activation by APCs
  • transduction transduction
  • short-term cell culture short-term cell culture
  • target microbubbles 55 may be introduced within the processing chamber 26 for binding.
  • a centrifugation protocol may be used to separate bound isolated cells (e.g., microbubbles 55 attached to target cells 146) from nontarget cells 145 in the processing chamber 26.
  • the non-targeted cells 146 can be expelled from the processing chamber 26 by moving the piston 29 downwards with the use of the hydraulic pump 123 either during centrifugation or by having the rotor 13 stationary.
  • valve 102 and valve 143 open to expel the non-targeted cells 145 towards waste bag 95.
  • a washing process may be performed to isolated target cells 53 by loading buffer from buffer bag 113 within the processing chamber 26 due to the movement of piston 29 upwards with the use of the hydraulic pump 123.
  • mixing of the contents of the processing chamber 26 may be performed with the use of mixing device 24. This process may be performed repeatedly based on protocol.
  • Step 9 (FIG 13.1): Alternatively, PLAX may be used solely for fraction separation and collection, therefore fraction #3 (mononuclear cells 53) can be extracted from the processing chamber 26 under centrifugation.
  • the cells transition towards the fraction collection container 97 by moving the piston 29 downwards with the use of the hydraulic pump 123 and opening valve 100 and valve 143, which respectively correspond to fraction collection container 97 and hydraulic pump 123.
  • Step 10 Fraction #4 (plasma 54) can be extracted from the processing chamber 26 under centrifugation.
  • the cells transition towards fraction container 98 by moving the piston 29 downwards with the use of the hydraulic pump 123 and opening valve 101 and valve 143, which respectively correspond to fraction container 98 and hydraulic pump 123.
  • Plasma 54 may be collected, or in the alternative may be re-routed towards waste bag 95 and extracted.
  • FIGs. 14A and 14B show bar plots graphing accuracy (%) over pumping steps (mb) for reagents in and reagents out, respectively, for a hydraulic pump 123.
  • the reagents in accuracy for the hydraulic pump 123 at 4.9 mb was 97.22 ⁇ 2.78 %, while reagents out accuracy for the hydraulic pump 123 was 96.88 ⁇ 3.02 %.
  • FIGs. 14C and 14D show bar plots graphing accuracy (%) over pumping steps (mb) for reagents towards cassette 16 and flush PBS/washing, respectively, for a peristaltic pump 108.
  • the reagents towards cassette 16 for the peristaltic pump 108 was 94.89 ⁇ 5.11 %, while the flush PBS/washing accuracy was 92.20 ⁇ 7.80 %.
  • FIG. 14E shows a comparison of the accuracy of the respective plots in Figures 14A-14D.
  • the difference between groups is very significant, with a p-value ⁇ 0.005.
  • the volume control by hydraulic pump 123 is highly accurate (97.10 ⁇ 2.90 %).
  • FIG. 15 displays exemplary plots of the different pressurization and depressurization profiles/pattems used when disrupting/dissolving microbubbles 55 bound to target cells 146.
  • the processing chamber 26 may need to undergo a premixing and/or constant mixing process for solution homogenization. Pressurization with a fixed or variable mixing speed may be achieved by the mixing device 24.
  • the mixing speed may be fully controllable by the PLAX system, and may include up to 360-degree rotation.
  • the speed of the piston 29 within the processing chamber 26 can be controlled and adjusted to provide full flexibility for microbubble target cell dissolution, and optimized automated parameters may be incorporated within the PLAX system.
  • the top left graph shows a plurality of hyperbolic pressurization curves for pressure (psi) over time (seconds).
  • the respective curves show achieving a pressure from 0 psi to 15-17.5 psi for time intervals of 10, 50, 75, 100, 150, and 250 seconds.
  • the bottom left shows a hyperbolic depressurization plot for pressure (psi) over time (seconds), wherein pressure decreases from ⁇ 7.5 psi to 0 psi within 60 seconds.
  • the top central graph shows a plurality of linear pressurization plots for pressure (psi) over time (seconds).
  • the respective curves show achieving a pressure from 0 psi to 15-17.5 psi for time intervals of 25, 40, andl75 seconds.
  • the bottom central graph shows a plurality of linear depressurization plots for pressure (psi) over time (seconds).
  • the respective curves show pressure decreases from 7-7.5 psi to 0 psi for time intervals of 35, 60, and 70 seconds.
  • the top right graph shows a stepwise pressurization plot for pressure (psi) overtime (seconds) from 0 psi to 15 psi over 80 seconds.
  • the bottom right shows a stepwise depressurization plot for pressure (psi) over time (seconds) from 15 psi to 0 psi over 80 seconds.
  • the pressurization and depressurization profiles for this process are not limited to the use of the piston 29, and may fully adjustable when employing a compressor or pump during the process. These profiles may range from linear, stepwise, hyperbolic or a variation of these over time until the system reaches the required pressure (e.g., 1.5, 2, 2.5 atm) for partially or completely disrupting microbubbles 55. Following dissolution of microbubbles 55, targeted cells 146 return to the solution, which can be used for sequential steps. The sequential steps may include binding to another type of targeted microbubble, activation by aAPCs, or viral transduction mediated by aVPCs. The three steps can occur within the same processing chamber 26.
  • PLAX invention can take on different forms or variations without straying from the fundamental essence of its key attributes. Therefore, all embodiments that fall within the scope and equivalence of the claims are intended to be encompassed by those claims.
  • Embodiment 1 A closed system for blood sample processing to separate biological components, said system comprising: a centrifuge having a rotor, said centrifuge being configured to centrifugate a blood sample; a processing chamber attached to the rotor, said processing chamber having a first end and a second end, and is configured to contain at least one blood sample; a piston housed in the processing chamber, said piston configured to move between the first position closer to a first end of the processing chamber and second position closer to a second end of the processing chamber, the second end being located opposite of the first end; and a plurality of tubes connecting the processing chamber to the at least one blood sample; wherein actuation of the piston making the piston move dispels fractions of the blood sample during centrifugation or at rest to at least one fraction bag.
  • Embodiment 4 The system according to one of the preceding embodiments 1-3, wherein the processing chamber is removably held in the swinging bucket cassette, which comprises a first swinging bucket cassette part that can be separated from a second swinging bucket cassette part to open the cassette for inserting or removing the processing chamber, and further comprises a releasable locking mechanism configured to interface with the swinging bucket cassette for holding the first and second swinging bucket cassette parts together.
  • the processing chamber is removably held in the swinging bucket cassette, which comprises a first swinging bucket cassette part that can be separated from a second swinging bucket cassette part to open the cassette for inserting or removing the processing chamber, and further comprises a releasable locking mechanism configured to interface with the swinging bucket cassette for holding the first and second swinging bucket cassette parts together.
  • Embodiment 5 The system according to one of the preceding embodiments 1-4, further comprising a peristaltic pump configured to route, re-direct, and/or move liquid from the processing chamber to a waste collection bag.
  • a peristaltic pump configured to route, re-direct, and/or move liquid from the processing chamber to a waste collection bag.
  • Embodiment 6 The system according to one of the preceding embodiments 1-5, wherein the processing chamber is cylindrical and the piston is a free-piston dividing the processing chamber into a first processing chamber part facing the blood sample and a second processing chamber part to which hydraulic fluid is fed or withdrawn by a hydraulic pump for moving the piston between said first and second positions.
  • Embodiment 7 The system according to embodiment 1, wherein the hydraulic pump employs a stepper motor coupled to a leadscrew via a shaft coupling connector to drive a plunger-flange within a processing buffer container to feed hydraulic fluid through a hydraulic tubing into the second processing chamber part.
  • O-ring tubing connector (upper body) tubing connector (lower body) inlet cavities outlet cavities hydraulic tubing input tubing input retaining channels output tubing output retaining channels hinge pattern reciprocal cassette counterpart reciprocal cassette pocket bushing physical support counterpart pattern release latch mechanism erythrocytes (RBCs) density gradient media mononuclear cells plasma microbubbles targeted microbubble-based cell isolation movi ng/extending/ reaching structure cassette bottom movable pressurization platform linear rail shaft optical axis rod lead screw shaft coupling connector stepper motor top support structure bottom support structure rotational elements sensor cavity-coupling integrations weight cells syringe attachment flange holder barrel flange processing buffer container plunger stepper motor support structure rotational elements lead screw translation adapter plurality of holes plurality of holes indentations rod mixer clamp mechanism multiple input reagent containers ceiling cap filter tubing connector rotational elements support structure connector/adapter stepper motor stepper motor housing housing sensor hook connector waste bag fraction collection container fraction collection container fraction collection container individual external pinch valve multichannel external pinch valve multichannel external pinch valve valve pre

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Clinical Laboratory Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Centrifugal Separators (AREA)
  • External Artificial Organs (AREA)

Abstract

L'invention concerne un système fermé pour le traitement d'échantillons de sang pour séparer des composants biologiques, et des procédés de sélection de cellules à partir d'un échantillon de sang. Le système comprend une centrifugeuse ayant un rotor, une chambre de traitement contenant un échantillon de sang, et un piston logé dans la chambre de traitement. Une pluralité de tubes relie la chambre de traitement à l'échantillon de sang. L'actionnement du piston élimine les fractions de l'échantillon de sang pendant la centrifugation ou au repos vers au moins un sac de fraction. La chambre de traitement peut être déplacée entre une orientation horizontale qui est adoptée pendant la centrifugation, et une position verticale alors qu'aucune centrifugation n'est effectuée.
PCT/US2024/021769 2024-03-27 2024-03-27 Système automatisé fermé et procédé de traitement de cellules multiplex Pending WO2025207088A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/US2024/021769 WO2025207088A1 (fr) 2024-03-27 2024-03-27 Système automatisé fermé et procédé de traitement de cellules multiplex

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2024/021769 WO2025207088A1 (fr) 2024-03-27 2024-03-27 Système automatisé fermé et procédé de traitement de cellules multiplex

Publications (1)

Publication Number Publication Date
WO2025207088A1 true WO2025207088A1 (fr) 2025-10-02

Family

ID=97219358

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2024/021769 Pending WO2025207088A1 (fr) 2024-03-27 2024-03-27 Système automatisé fermé et procédé de traitement de cellules multiplex

Country Status (1)

Country Link
WO (1) WO2025207088A1 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061381A (en) * 1990-06-04 1991-10-29 Abaxis, Inc. Apparatus and method for separating cells from biological fluids
US5663051A (en) * 1994-08-31 1997-09-02 Activated Cell Therapy, Inc. Separation apparatus and method
EP0794824B1 (fr) * 1994-12-02 2008-08-20 Vivolution A/S Dispositif et procede de separation du monomere de la fibrine i du plasma sanguin
WO2011052910A2 (fr) * 2009-10-28 2011-05-05 주식회사 글로텍 Kit de séparation centrifuge, et procédé de séparation centrifuge utilisant ledit kit
KR20190026585A (ko) * 2017-09-05 2019-03-13 이준석 원심분리용 피스톤 및 이를 포함하는 원심분리 장치

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061381A (en) * 1990-06-04 1991-10-29 Abaxis, Inc. Apparatus and method for separating cells from biological fluids
US5663051A (en) * 1994-08-31 1997-09-02 Activated Cell Therapy, Inc. Separation apparatus and method
EP0794824B1 (fr) * 1994-12-02 2008-08-20 Vivolution A/S Dispositif et procede de separation du monomere de la fibrine i du plasma sanguin
WO2011052910A2 (fr) * 2009-10-28 2011-05-05 주식회사 글로텍 Kit de séparation centrifuge, et procédé de séparation centrifuge utilisant ledit kit
KR20190026585A (ko) * 2017-09-05 2019-03-13 이준석 원심분리용 피스톤 및 이를 포함하는 원심분리 장치

Similar Documents

Publication Publication Date Title
US6733433B1 (en) Blood separation system particularly for concentrating hematopoietic stem cells
US5672481A (en) Apparatus and method for particle separation in a closed field
EP1011752B1 (fr) Appareil et procede de traitement de cellules biologiques
US5429803A (en) Liquid specimen container and attachable testing modules
US9101925B2 (en) Centrifuge and separation vessel therefore
JP7248324B2 (ja) コンパクトな逆流遠心分離システムおよびそれに用いる分離チャンバ
US10099228B2 (en) Apparatus for performing counter flow centrifugation and method of using same
CN113396211A (zh) 细胞处理单元、细胞处理系统及其使用方法
US20250303031A1 (en) Closed automated system and method for multiplex cell processing
WO2025207088A1 (fr) Système automatisé fermé et procédé de traitement de cellules multiplex
EP3922711A1 (fr) Dispositif de traitement d'échantillon
WO2024103070A1 (fr) Systèmes et dispositifs de préparation et/ou de perfusion de thérapie par suspension et procédés d'utilisation
WO2025213101A1 (fr) Systèmes, dispositifs et kits microfluidiques pour la préparation et/ou la perfusion de thérapie par suspension, et procédés d'utilisation
CN113329809A (zh) 用于生产细胞疗法产品的装置
JP2023545378A (ja) 自動化された細胞工学システムのための滅菌サンプリング方法及びデバイス

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24932907

Country of ref document: EP

Kind code of ref document: A1